New results from a once-promising therapy show the difficulty of treating covid-19 – The Washington Post

But those observations were limited by tiny sizes. One of the first studies to highlight tocilizumabs potential, conducted in February, included only 21 patients. Those results have not been broadly replicated a testament to the difficulty of gauging a treatments effectiveness on the fly when presented with diverse patients at different stages of illness.
Of the trio of new studies, the largest an observational study involving about 4,000 people compared patients who received tocilizumab within…

Click here to view the original article.